4.5 Article

N-Acetyl-L-cysteine exacerbates generation of IL-10 in cells stimulated with endotoxin in vitro and produces antipyresis via IL-10 dependent pathway in vivo

期刊

IMMUNOLOGY LETTERS
卷 177, 期 -, 页码 1-5

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.imlet.2016.06.005

关键词

Fever; Endotoxin; N-Acetyl-L-cysteine; Antipyresis; IL-10

资金

  1. Universitatis Nicolai Copernici Foundation (Amicus), Poland [53/2011]

向作者/读者索取更多资源

N-Acetyl-L-cysteine (NAC) is a well-known medication, primarily used as a mucolytic agent in pulmonary disease. Recently, we have found that NAC possesses antipyretic properties. The aim of the present study was to investigate the mechanism by which NAC attenuates fever. The concentration of interleukin (IL)-10 and prostaglandin (PG) E-2 were measured using ELISA kit in the supernatants aspirated after stimulation of peripheral blood mononuclear cells (PBMCs) with lipopolysaccharide (LPS, 1 mu g/mL) and NAC (10 mM). The body temperature of the Wistar rats was measured using biotelemetry system. To inhibit endotoxic fever, NAC (200 mg/kg; i.p.) was injected into the rats one hour prior to the LPS administration (50 mu g/kg; i.p.). The pre-treatment of LPS-stimulated PBMCs with NAC resulted in a significant decrease in PGE(2) concentration in comparison to the cells treated with LPS alone (PGE2 level was 386.1 +/- 61.9 pg/mL vs. 2078.9 +/- 157.9 pg/mL, respectively, p < 0.001). Furthermore, in these cells we observed a significant increase in IL -10 level (142.1 +/- 2.62 pg/mL in NAC + LPS stimulated cells vs. 54.4 +/- 0.6 pg/mL in LPS stimulated cells, p <0.001). The injection of anti-IL-10 antibody into the rats abolished antipyretic properties of NAC. Body temperature in animals treated with anti-IL-10 + NAC/LPS was 38.28 +/- 0.12 degrees C vs. 37.73 +/- 0.06 C in IgG + NAC/LPS rats (p < 0.001) and 3831 +/- 0.20 degrees C in NaCl/LPS-treated animals (n.s.). Based on these data, we conclude that NAC acts as an antipyretic via IL -10 stimulation. This finding provides a new insight into the immunopharmacology of NAC, and we believe that in a future it will contribute to the new and/or more accurate application of NAC in medicine. (C) 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据